These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 3536423)

  • 1. Oxaprozin. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Todd PA; Brogden RN
    Drugs; 1986 Oct; 32(4):291-312. PubMed ID: 3536423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tiaprofenic acid. A review of its pharmacological properties and therapeutic efficacy in rheumatic diseases and pain states.
    Sorkin EM; Brogden RN
    Drugs; 1985 Mar; 29(3):208-35. PubMed ID: 3886353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nabumetone. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in rheumatic diseases.
    Friedel HA; Todd PA
    Drugs; 1988 May; 35(5):504-24. PubMed ID: 3293969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fenbufen: a review of its pharmacological properties and therapeutic use in rheumatic diseases and acute pain.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1981 Jan; 21(1):1-22. PubMed ID: 7009135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxaprozin versus aspirin in rheumatoid arthritis: a double-blind trial.
    Jamar R; Dequeker J
    Curr Med Res Opin; 1978; 5(6):433-8. PubMed ID: 350495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenoxicam. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Gonzalez JP; Todd PA
    Drugs; 1987 Sep; 34(3):289-310. PubMed ID: 3315620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxaprozin: a once-daily nonsteroidal anti-inflammatory drug.
    Miller LG
    Clin Pharm; 1992 Jul; 11(7):591-603. PubMed ID: 1617910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flurbiprofen: a review of its pharmacological properties and therapeutic use in rheumatic diseases.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1979 Dec; 18(6):417-38. PubMed ID: 391529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic and gastrointestinal safety comparisons of etodolac, nabumetone, and oxaprozin from insurance claims data from patients with arthritis.
    Simon LS; Zhao SZ; Arguelles LM; Lefkowith JB; Dedhiya SD; Fort JG; Johnson KE
    Clin Ther; 1998; 20(6):1218-35; discussion 1192-3. PubMed ID: 9916614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proquazone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in rheumatic diseases and pain states.
    Clissold SP; Beresford R
    Drugs; 1987 May; 33(5):478-502. PubMed ID: 3297621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The analgesic and antipyretic effects of a non-steroidal anti-inflammatory drug, oxaprozin, in experimental animals].
    Amanuma F; Okuyama S; Orikasa S; Hashimoto S; Yamada C; Sakagawa T; Tsutsui Y; Tarumoto Y; Aihara H; Kameyama T
    Nihon Yakurigaku Zasshi; 1984 Apr; 83(4):345-54. PubMed ID: 6611288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxaprozin: kinetic and dynamic profile in the treatment of pain.
    Kean WF
    Curr Med Res Opin; 2004 Aug; 20(8):1275-7. PubMed ID: 15324530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxaprozin-induced fulminant hepatitis.
    Purdum PP; Shelden SL; Boyd JW; Shiffman ML
    Ann Pharmacother; 1994 Oct; 28(10):1159-61. PubMed ID: 7841569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The inhibitory effect of oxaprozin, a new non-steroidal anti-inflammatory drug, on platelet aggregation].
    Goto J; Muramatsu M; Hosoda K; Otomo S; Aihara H
    Nihon Yakurigaku Zasshi; 1984 May; 83(5):395-400. PubMed ID: 6432657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-inflammatory activity of a non-steroidal anti-inflammatory agent, oxaprozin, in experimental models].
    Higuchi S; Osada Y; Shioiri Y; Nakaike S; Muramatsu M; Tanaka M; Arai I; Amanuma F; Otomo S; Aihara H
    Nihon Yakurigaku Zasshi; 1984 May; 83(5):383-94. PubMed ID: 6432656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pirprofen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Todd PA; Beresford R
    Drugs; 1986 Dec; 32(6):509-37. PubMed ID: 3539573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Meta-analysis on the effect and adverse reaction on patients with osteoarthritis and rheumatoid arthritis treated with non-steroidal anti-inflammatory drugs].
    Shi W; Wang YM; Cheng NN; Chen BY; Li D
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov; 24(11):1044-8. PubMed ID: 14687510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxaprozin and sulindac in rheumatoid arthritis: a double-blind comparative trial.
    Zuccollo R; Mackinnon MJ; Fraser KM; Hall SM; Palmer DG
    Curr Med Res Opin; 1983; 8(5):302-9. PubMed ID: 6340971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the emerging profile of the anti-inflammatory drug oxaprozin.
    Dallegri F; Bertolotto M; Ottonello L
    Expert Opin Pharmacother; 2005 May; 6(5):777-85. PubMed ID: 15934904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of selected newer nonsteroidal anti-inflammatory drugs.
    Cummings DM; Amadio P
    Am Fam Physician; 1994 Apr; 49(5):1197-202. PubMed ID: 8154406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.